IBDEI1V9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33240,1,3,0)
 ;;=3^Path fx in neoplst disease, rt ankl, init
 ;;^UTILITY(U,$J,358.3,33240,1,4,0)
 ;;=4^M84.571A
 ;;^UTILITY(U,$J,358.3,33240,2)
 ;;=^5014172
 ;;^UTILITY(U,$J,358.3,33241,0)
 ;;=M84.572A^^191^1968^387
 ;;^UTILITY(U,$J,358.3,33241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33241,1,3,0)
 ;;=3^Path fx in neoplst disease, lft ankl, init
 ;;^UTILITY(U,$J,358.3,33241,1,4,0)
 ;;=4^M84.572A
 ;;^UTILITY(U,$J,358.3,33241,2)
 ;;=^5014178
 ;;^UTILITY(U,$J,358.3,33242,0)
 ;;=M80.871A^^191^1968^408
 ;;^UTILITY(U,$J,358.3,33242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33242,1,3,0)
 ;;=3^Path fx rt ank/ft, oth, init
 ;;^UTILITY(U,$J,358.3,33242,1,4,0)
 ;;=4^M80.871A
 ;;^UTILITY(U,$J,358.3,33242,2)
 ;;=^5013543
 ;;^UTILITY(U,$J,358.3,33243,0)
 ;;=M80.872A^^191^1968^391
 ;;^UTILITY(U,$J,358.3,33243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33243,1,3,0)
 ;;=3^Path fx lft ank/ft, oth init
 ;;^UTILITY(U,$J,358.3,33243,1,4,0)
 ;;=4^M80.872A
 ;;^UTILITY(U,$J,358.3,33243,2)
 ;;=^5133943
 ;;^UTILITY(U,$J,358.3,33244,0)
 ;;=M84.671A^^191^1968^410
 ;;^UTILITY(U,$J,358.3,33244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33244,1,3,0)
 ;;=3^Path fx rt ankl, oth disease, init
 ;;^UTILITY(U,$J,358.3,33244,1,4,0)
 ;;=4^M84.671A
 ;;^UTILITY(U,$J,358.3,33244,2)
 ;;=^5014292
 ;;^UTILITY(U,$J,358.3,33245,0)
 ;;=M84.672A^^191^1968^393
 ;;^UTILITY(U,$J,358.3,33245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33245,1,3,0)
 ;;=3^Path fx lft ankl, oth disease, init
 ;;^UTILITY(U,$J,358.3,33245,1,4,0)
 ;;=4^M84.672A
 ;;^UTILITY(U,$J,358.3,33245,2)
 ;;=^5134027
 ;;^UTILITY(U,$J,358.3,33246,0)
 ;;=M84.474A^^191^1968^413
 ;;^UTILITY(U,$J,358.3,33246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33246,1,3,0)
 ;;=3^Path fx rt ft, init enc
 ;;^UTILITY(U,$J,358.3,33246,1,4,0)
 ;;=4^M84.474A
 ;;^UTILITY(U,$J,358.3,33246,2)
 ;;=^5013980
 ;;^UTILITY(U,$J,358.3,33247,0)
 ;;=M84.475A^^191^1968^397
 ;;^UTILITY(U,$J,358.3,33247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33247,1,3,0)
 ;;=3^Path fx lft ft, init enc
 ;;^UTILITY(U,$J,358.3,33247,1,4,0)
 ;;=4^M84.475A
 ;;^UTILITY(U,$J,358.3,33247,2)
 ;;=^5013986
 ;;^UTILITY(U,$J,358.3,33248,0)
 ;;=M84.674A^^191^1968^414
 ;;^UTILITY(U,$J,358.3,33248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33248,1,3,0)
 ;;=3^Path fx rt ft, oth disease, init
 ;;^UTILITY(U,$J,358.3,33248,1,4,0)
 ;;=4^M84.674A
 ;;^UTILITY(U,$J,358.3,33248,2)
 ;;=^5014298
 ;;^UTILITY(U,$J,358.3,33249,0)
 ;;=M84.675A^^191^1968^398
 ;;^UTILITY(U,$J,358.3,33249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33249,1,3,0)
 ;;=3^Path fx lft ft, oth disease, init
 ;;^UTILITY(U,$J,358.3,33249,1,4,0)
 ;;=4^M84.675A
 ;;^UTILITY(U,$J,358.3,33249,2)
 ;;=^5134039
 ;;^UTILITY(U,$J,358.3,33250,0)
 ;;=M84.574A^^191^1968^390
 ;;^UTILITY(U,$J,358.3,33250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33250,1,3,0)
 ;;=3^Path fx in neoplst disease, rt foot, init
 ;;^UTILITY(U,$J,358.3,33250,1,4,0)
 ;;=4^M84.574A
 ;;^UTILITY(U,$J,358.3,33250,2)
 ;;=^5014190
 ;;^UTILITY(U,$J,358.3,33251,0)
 ;;=M84.575A^^191^1968^388
 ;;^UTILITY(U,$J,358.3,33251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33251,1,3,0)
 ;;=3^Path fx in neoplst disease, lft ft, init
 ;;^UTILITY(U,$J,358.3,33251,1,4,0)
 ;;=4^M84.575A
 ;;^UTILITY(U,$J,358.3,33251,2)
 ;;=^5014196
 ;;^UTILITY(U,$J,358.3,33252,0)
 ;;=M84.477A^^191^1968^417
 ;;^UTILITY(U,$J,358.3,33252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33252,1,3,0)
 ;;=3^Path fx rt toe(s), init
 ;;^UTILITY(U,$J,358.3,33252,1,4,0)
 ;;=4^M84.477A
